Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Neovasc reports record revenues in Q1 2014

Neovasc Inc. ("Neovasc" or the "Company"), today announced financial results for the three months ended March 31, 2014. "The first quarter of 2014 was marked by major developments at Neovasc," noted Alexei Marko, chief executive officer of Neovasc.

22 May 2014

New 5-layer flask enhances cell culture production

Porvair Sciences has announced a new 5-layer cell culture flask developed to fulfil the need of the growing number of applications that require large numbers of cells.

From Chromatrap® - Porvair Sciences Ltd 22 May 2014

Leica Microsystems and Med X Change announce select Leica surgical microscopes are now available with integrated 1080p recording

Leica Microsystems and Med X Change announce that select Leica surgical microscopes are now available with integrated 1080p video recording and still image capture. The compact Med X Change EvolutionHD 2D Medical Video Recorder, EVO for short, seamlessly integrates with the microscope stands, providing high definition video recording without interrupting surgical workflow. This small, powerful, high end medical video recorder with state-of-the-art features delivers surgical content automatically to Apple® iPad and iPhone mobile devices. Leica Microsystems presented the system at the American Society of Cataract and Refractive Surgery / American Society of Ophthalmic Administrators Symposium & Congress, April 25-29, 2014, in Boston, MA, USA.

20 May 2014

BioLineRx announces financial results for Q1 2014, provides operational update

BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, today reported its financial results for first quarter ended March 31, 2014.

20 May 2014

Existing pharmaceutical drugs may offer effective therapies against MERS

A series of research articles published ahead of print in the journal Antimicrobial Agents and Chemotherapy have identified a number of existing pharmaceutical drugs and compounds under development that may offer effective therapies against Middle East Respiratory Syndrome (MERS).

20 May 2014

DNA-directed RNA interference and hepatitis C: an interview with Carl Stubbings, Chief Business Officer, Benitec Biopharma

RNA interference (RNAi) is a naturally occurring process, which cells can use to silence, or ‘turn off’ unwanted genes.

From Quest Diagnostics 19 May 2014

Shire intends to submit NDA for lifitegrast to treat dry eye disease

Following a May 15, 2014, meeting with the U.S. Food and Drug Administration (FDA), Shire plc, the global specialty biopharmaceutical company, announces today that it intends to submit a New Drug Application for lifitegrast as a treatment for the signs and symptoms of dry eye disease in adults in the first-quarter 2015, as we complete remaining chemistry and manufacturing work.

19 May 2014

Bio-Path Holdings reports net loss of $504,876 for first quarter 2014

Bio-Path Holdings, Inc., a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced operational and financial results for the first quarter ended March 31, 2014.

17 May 2014

TCM announces winners of 26th Annual Industry Awards

The Tech Council of Maryland (TCM), Maryland's largest technology trade association for life science and technology, today announced the winners of its 26th Annual Industry Awards.

16 May 2014

Abbott signs definitive agreement to acquire CFR Pharmaceuticals

Abbott today announced a definitive agreement to acquire Latin American pharmaceutical company CFR Pharmaceuticals, more than doubling its Latin American branded generics pharmaceutical presence and further expanding Abbott's presence in fast-growing markets.

16 May 2014

Rep. Jan Schakowsky visits Wockhardt plant, commends production expansion in Illinois

Rep. Jan Schakowsky visited Wockhardt's Morton Grove facility with a goal in mind: strengthening efforts to revitalize American manufacturing.

15 May 2014

Introduction to Solid State ChIP technology

A new instructional video from Porvair Sciences explains exactly how to conduct a ChIP assay for epigenetic research starting from a confluent monolayer of human cells.

From Chromatrap® - Porvair Sciences Ltd 14 May 2014

Aradigm reports total revenue of $6.6 million for Q1 2014

Aradigm Corporation today announced financial results for the first quarter and three months ended March 31, 2014.

14 May 2014

Researchers develop chip-like device to sort, store and retrieve individual living cells for study

A U.S. and Korean research team has developed a chip-like device that could be scaled up to sort and store hundreds of thousands of individual living cells in a matter of minutes. The system is similar to a random access memory chip, but it moves cells rather than electrons.

14 May 2014

GE Healthcare, Tesla Engineering announce collaboration to develop ultra high-field MRI systems

Today at the joint meeting of the International Society for Magnetic Resonance in Medicine and the European Society for Magnetic Resonance in Medicine and Biology, GE Healthcare and Tesla Engineering Ltd. announced that they will collaborate together to produce 7.0 tesla (7.0T) human whole-body magnetic resonance imaging (MRI) scanners, and build upon the ten year history of GE innovations in this advanced, technical field.

12 May 2014

Stratasys' total non-GAAP revenue grows by 54% in first quarter 2014

Stratasys Ltd. today announced first quarter financial results.

9 May 2014

Experimental antibody temporarily halts progression of neuroblastoma in children

Tumors shrank or disappeared and disease progression was temporarily halted in 15 children with advanced neuroblastoma enrolled in a safety study of an experimental antibody produced at St. Jude Children's Research Hospital.

9 May 2014

Grace introduces ProVance Pre-packed Protein A Columns for mAb purification

W. R. Grace & Co. has introduced ProVance Pre-packed Protein A Columns, for purification of biologic drugs, specifically monoclonal antibodies (mAbs). Monoclonal antibodies represent the single largest biologics therapeutic category in the clinical development pipeline.

9 May 2014

Viewpoints: Insurance and death rates; Massachusetts 'exit plan'; Obamacare premiums

Alert (or at least health-care-obsessed) readers have no doubt been following the coverage of a new study on mortality in Massachusetts in the years following Romneycare's coverage expansion.

9 May 2014

Emergent BioSolutions reports total revenue of $53.9 million for Q1 2014

Emergent BioSolutions Inc. reported total revenue for Q1 2014 of $53.9 million as compared to $43.1 million in 2013. In addition, Q1 2014 net loss was $20.2 million, or $0.55 per share, as compared to a net loss of $8.1 million, or $0.22 per share, in 2013.

9 May 2014